Related Topics:
Facility ID: 9402WCSBCX2KELL
Facility Name and Address: CSBIO 20 KELLY CT MENLO PARK, CA 94025 Parent Company: CSBIO Industry: Pharmaceutical Preparation Manufacturing (325412) Chemical: Dichloromethane Reports: View TRI Facility profile report for this facility View TRI Form R submissions by this facility |
|
*You can navigate within the map with your mouse. |
Production Related Waste Management for Selected Chemical
lchemid=0000075092
Chart Options1: |
Waste Management Comparison -
Display facility comparison report for this industry and chemical
Display facility comparison report for this parent company
Pollution Prevention Activities for Selected Chemical
Reporting Year | Section 8.10: Newly Implemented Source Reduction Activity | Section 8.10: Methods to Identify Activity | Section 8.11: Optional Pollution Prevention Information* |
---|---|---|---|
2020 |
Source Reduction:: W56: Reduced or eliminated use of an organic solvent[-15-24%]
|
Methods to Identify SR Opportunities: T03: Materials balance audits
Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction. |
W56: Reduced / Removed usage of solvent in process and all new processes. Still present in prior established processes due to regulated environment regarding changes to existing processes. Source Reduction - Source reduction activity due calculated from material balance audits for volume of solvent used as well as calculation of the theoretical volume of the removed solvent. Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - Materials must meet GMP standards and are an approved process |
2019 |
Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.
|
Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - Dichloromethane is being phased out from being used in any new future product projects. Existing products using dichloromethane cannot be altered due to their GMP approval process. |
|
2018 |
Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.
|
Other Barriers to Source Reduction - Dichloromethane is being phased out from being used in any new future product projects. Existing products using dichloromethane cannot be altered due to their GMP approval process. Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - Materials must meet GMP standards and are an approved process |
|
2017 |
Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.
Barriers: B7-No Information B7 - No known substitutes or alternative technologies. |
Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - Materials must meet GMP standards and approved processes |
|
2016 |
Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.
|
Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - Materials must meet GMP standards and approved processes |
|
2015 |
Source Reduction:: W13: Improved maintenance scheduling, recordkeeping, or procedures[-0-4%]
|
Methods to Identify SR Opportunities: T04: Participative team management
|